Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema. [PDF]
J Vitreoretin DisGodel S, Oncel D, Donkor R, Coney JM.
europepmc +1 more source
Long-term outcomes of intravitreal 0.19 mg fluocinolone acetonide implant in uveitic macular edema after prior local corticosteroid treatments. [PDF]
J Ophthalmic Inflamm InfectFerreira AM +6 more
europepmc +1 more source
Can bionic eyes restore vision? Breakthroughs, challenges, and future frontiers in ophthalmology - A comprehensive review. [PDF]
J Biol EngChen KY, Chan HC, Chan CM.
europepmc +1 more source
Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema. [PDF]
Turk J OphthalmolKarataş G +7 more
europepmc +1 more source
Successful Cataract Surgery in a Patient with a Port Delivery System Implant for Diabetic Macular Edema. [PDF]
Case Rep OphthalmolChu J, Haddadin RI, Gill M.
europepmc +1 more source
Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]
Front Med (Lausanne)Ji M, Wei W, Gong H, Zhang G.
europepmc +1 more source
Dexamethasone implant vs. anti-VEGF for diabetic macular edema with epiretinal membrane: short-term outcomes. [PDF]
Int J Retina VitreousChang YC, Hsieh TC, Chan TY, He MS.
europepmc +1 more source
A Case of Anterior Vitreous Displacement of the Intravitreal Dexamethasone Implant (Ozurdex®) in a Pseudophakic Eye. [PDF]
CureusMahdar A, Dubois P.
europepmc +1 more source
Advances in artificial vision systems: a comprehensive review of technologies, applications, and future directions. [PDF]
Biomed Eng LettKim J, Seo JM.
europepmc +1 more source
Brain-Computer Interfaces for Vision Recovery in Precortical Vision Loss. [PDF]
Eye BrainYang CD, Guo A, Lin KY.
europepmc +1 more source